Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.

Poirier AA, Aubé B, Côté M, Morin N, Di Paolo T, Soulet D.

Parkinsons Dis. 2016;2016:6762528. doi: 10.1155/2016/6762528. Review.

2.

FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.

Vidal-Martínez G, Vargas-Medrano J, Gil-Tommee C, Medina D, Garza NT, Yang B, Segura-Ulate I, Dominguez SJ, Perez RG.

J Biol Chem. 2016 Sep 23;291(39):20811-21. doi: 10.1074/jbc.M116.744029.

3.

Chronic constipation: improved understanding offers a new therapeutic approach.

Sanger GJ.

J Physiol. 2016 Aug 1;594(15):4085-7. doi: 10.1113/JP272560. No abstract available.

PMID:
27477601
4.

The bowel and beyond: the enteric nervous system in neurological disorders.

Rao M, Gershon MD.

Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):517-28. doi: 10.1038/nrgastro.2016.107. Review.

5.

Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?

Ruffmann C, Parkkinen L.

Mov Disord. 2016 Feb;31(2):193-202. doi: 10.1002/mds.26480. Review.

6.

Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly.

Luo SX, Huang EJ.

Am J Pathol. 2016 Mar;186(3):478-88. doi: 10.1016/j.ajpath.2015.09.023. Review.

7.

Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.

Ito S, Takao M, Hatsuta H, Kanemaru K, Arai T, Saito Y, Fukayama M, Murayama S.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1714-23.

8.

Nonmotor symptoms in a malaysian Parkinson's disease population.

Azmin S, Khairul Anuar AM, Tan HJ, Nafisah WY, Raymond AA, Hanita O, Shah SA, Norlinah MI.

Parkinsons Dis. 2014;2014:472157. doi: 10.1155/2014/472157.

9.

The dopaminergic system in autoimmune diseases.

Pacheco R, Contreras F, Zouali M.

Front Immunol. 2014 Mar 21;5:117. doi: 10.3389/fimmu.2014.00117. Review.

10.

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Dorszewska J, Prendecki M, Oczkowska A, Rozycka A, Lianeri M, Kozubski W.

Curr Genomics. 2013 Dec;14(8):518-33. doi: 10.2174/1389202914666131210210241.

11.

Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.

Farrell KF, Krishnamachari S, Villanueva E, Lou H, Alerte TN, Peet E, Drolet RE, Perez RG.

J Neurochem. 2014 Feb;128(4):536-46. doi: 10.1111/jnc.12481.

12.

The human gastrointestinal tract, a potential autologous neural stem cell source.

Hagl CI, Heumüller-Klug S, Wink E, Wessel L, Schäfer KH.

PLoS One. 2013 Sep 4;8(9):e72948. doi: 10.1371/journal.pone.0072948.

13.
14.

Glutathione metabolism and Parkinson's disease.

Smeyne M, Smeyne RJ.

Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Review.

15.

Neurostimulation for neurogenic bowel dysfunction.

Worsøe J, Rasmussen M, Christensen P, Krogh K.

Gastroenterol Res Pract. 2013;2013:563294. doi: 10.1155/2013/563294.

16.

The pathology roadmap in Parkinson disease.

Surmeier DJ, Sulzer D.

Prion. 2013 Jan-Feb;7(1):85-91. doi: 10.4161/pri.23582. Review.

17.

Treatment of recurrent sigmoid volvulus in Parkinson's disease by percutaneous endoscopic colostomy.

Toebosch S, Tudyka V, Masclee A, Koek G.

World J Gastroenterol. 2012 Oct 28;18(40):5812-5. doi: 10.3748/wjg.v18.i40.5812.

18.

Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study.

Dobbs RJ, Charlett A, Dobbs SM, Weller C, A Ibrahim MA, Iguodala O, Smee C, Plant JM, Lawson AJ, Taylor D, Bjarnason I.

Gut Pathog. 2012 Oct 19;4(1):12. doi: 10.1186/1757-4749-4-12.

19.

Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss.

Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG.

Acta Neuropathol. 2012 Nov;124(5):665-80. doi: 10.1007/s00401-012-1040-2.

20.

Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Sulzer D, Surmeier DJ.

Mov Disord. 2013 Jan;28(1):41-50. doi: 10.1002/mds.25095. Review.

Items per page

Supplemental Content

Support Center